Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/1996
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996034614A1 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
11/07/1996WO1996034613A1 Endothelial lining effects and treatment of vasospastic disorders
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740552A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
11/06/1996EP0590034B1 Method for determining the presence of diabetes associated antibodies or islet cell directed antibodies
11/06/1996CN1134837A Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
11/06/1996CN1134818A Therapeutic method for rheumatic arthritis and recurrent and multiple chondropathy by using zymolysis of cartilage
11/06/1996CN1033214C Capsul for curing gastric ulcer
11/05/1996US5571801 Plasma expander and blood substitute
11/05/1996US5571784 Use of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
11/05/1996US5571515 Compositions and methods for use of IL-12 as an adjuvant
10/1996
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996033750A1 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996033719A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/31/1996WO1996017627A3 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells
10/31/1996WO1996013597A3 Improved adenovirus and methods of use thereof
10/31/1996DE19512227C1 Multifaktorielles Abwehr-Modulatorengemisch, Verfahren zu seiner Herstellung und diese Modulatoren enthaltende Arzneimittel Multifactorial defense modulator mixture, process for its preparation and pharmaceutical compositions containing these modulators
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2219272A1 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/30/1996EP0739632A1 Process for the preparation of a medical product
10/30/1996EP0739631A2 Laminar bone support for cartilage growth
10/30/1996EP0739630A2 Process and apparatus for the simultaneous elimination of tumor necrosis factor aplha and bacterial lipopolysaccharides from whole blood and/or blood plasma
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996CN1134724A Insulin-secreting cell lines, methods of production and use
10/30/1996CN1134671A Compositions for prevention and treatment of viral-induced tumors
10/30/1996CN1134301A Foot-washing antitussive lotion and its preparing method
10/30/1996CN1134300A Medicinal capsule for replenishing vital essence and marrow, beautifying and antisenility
10/30/1996CN1134295A Oral medicine for treating acute cerebrovascular disease
10/30/1996CN1134290A Tincture for traumatic injury
10/30/1996CN1134281A Medicine for asthma and its preparation
10/30/1996CN1134280A Lactein effervescent granule and its preparing method
10/30/1996CN1134240A Decolouring and deodorizing production method for buckwheat honey
10/29/1996US5569585 Stimulating non-resting immune cells to activity: stimulant dosage will activate primed cells but does not stimulate resting cells; measurement
10/29/1996US5569462 Placing a population of therapeutic substance producing cells into cell receiving chamber of immunoisolation apparatus, implanting apparatus into patient, administering an immunomodulatory agent
10/29/1996CA1338682C Biologically active undenatured whey protein concentrate as food supplement
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033280A1 An adenovirus helper-virus system
10/24/1996WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/24/1996WO1996033264A1 Purified and isolated sertoli cell aggregate
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996032969A1 Method for the microbial decontamination of blood platelets
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032953A1 A propolis extract and a process for its preparation
10/24/1996CA2218610A1 An adenovirus helper-virus system
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0579616B1 Method for extracting a biological substance from lepidoptera larvas and substance thus obtained
10/23/1996EP0574383B1 Color modified melanins and methods for their preparation and use
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/23/1996CN1133713A Young pilose antler blood kidney-mourishing liquid
10/23/1996CN1133688A Crisp bone black-bone chicken and its producing process
10/22/1996US5567443 Method of treating inflammatory diseases
10/22/1996US5567435 Mixing active material with a solution of polymerizable macromer comprising degradable region and free radical polymerizable end groups
10/22/1996US5567417 Method for inhibiting angiogenesis using heparinase
10/17/1996WO1996032489A1 Glucose-inducible recombinant viral vector
10/17/1996WO1996032483A1 Immune-evading proteins
10/17/1996WO1996032482A1 Bacteriocins
10/17/1996WO1996032199A1 Centrifugal system for spillover collection of sparse components such as mononuclear cells
10/17/1996WO1996032198A1 Centrifuged system for intermittent collection of mononuclear cells
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032140A1 Methods for engineering artificial veto cells
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032117A1 Bioactive concentrate, its producing method and certain drug compositions containing also chondroitin sulphate
10/17/1996WO1996032087A2 Transgenic fish in the treatment of diabetes
10/17/1996DE19514694A1 Broad spectrum antiinfective agent
10/17/1996DE19513540A1 Use of propolis, administered non-topically, opt. in combination with casein
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0663833B1 Royal jelly
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133189A Oral liquid for body building up
10/16/1996CN1133188A Production method of traditional Chinese medicine pills for hyperostosis
10/16/1996CN1133181A Qiangweisan (medicinal powder for invigorating the function of stomach) preparation process
10/16/1996CN1133174A Health care food using snail, ant and Pullas pit viper and raw material
10/16/1996CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996US5565214 Stable therapeutic oil filled soft gelatin capsules
10/15/1996US5565198 Zona pellucida as a growth stimulant
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 1259